TY - JOUR
T1 - Large Induction of Type III Deiodinase Expression After Partial Hepatectomy in the Regenerating Mouse and Rat Liver
AU - Kester, Monique
AU - Toussaint, MJM
AU - Punt, CA
AU - Matondo, R
AU - Aarnio, AM (Anne)
AU - Darras, VM
AU - Everts, ME (Marjanne)
AU - Bruin, A (Alain)
AU - Visser, Theo
PY - 2009
Y1 - 2009
N2 - The deiodinase types 1 (D1) and 2 (D2) catalyze the activation of T-4 to T-3, whereas type 3 deiodinase (D3) catalyzes the inactivation of T-3 and T-4. D3 plays a key role in controlling thyroid hormone bioavailability. It is highly expressed during fetal development, but also in other processes with increased cell proliferation, e. g. in vascular tumors. Because tissue regeneration is dependent on cellular proliferation and is associated with activation of fetal genes, we evaluated deiodinase activities and mRNA expression in rat and mouse liver, as well as the local and systemic thyroid hormone status after partial hepatectomy (PH). We observed that in rats, D3 activity was increased 10-fold at 20 h and 3-fold at 48 h after PH; D3 mRNA expression was increased 3-fold at 20 h. The increase in D3 expression was associated with maximum 2-to 3-fold decreases of serum and liver T-3 and T-4 levels at 20 to 24 h after PH. In mice, D3 activity was increased 5-fold at 12 h, 8-fold at 24 h, 40-fold at 36 h, 15-fold at 48 h, and 7-fold at 72 h after PH. In correlation with this, D3 mRNA was highest (6-fold increase), and serum T-3 and T-4 were lowest at 36 h. Furthermore, as a measure for cell proliferation, 5-bromo-2'-deoxyuridine incorporation peaked at 20-24 h after PH in rats and at 36 h in mice. No significant effect on D1 activity or mRNA expression was found after PH. D2 activity was always undetectable. In conclusion, we found a large induction of hepatic D3 expression after PH that was correlated with an increased cellular proliferation and decreased serum and liver T-3 and T-4 levels. Our data suggest that D3 is important in the modulation of thyroid hormone levels in the regenerating liver, in which a decrease in cellular T-3 permits an increase in proliferation. (Endocrinology 150: 540-545, 2009)
AB - The deiodinase types 1 (D1) and 2 (D2) catalyze the activation of T-4 to T-3, whereas type 3 deiodinase (D3) catalyzes the inactivation of T-3 and T-4. D3 plays a key role in controlling thyroid hormone bioavailability. It is highly expressed during fetal development, but also in other processes with increased cell proliferation, e. g. in vascular tumors. Because tissue regeneration is dependent on cellular proliferation and is associated with activation of fetal genes, we evaluated deiodinase activities and mRNA expression in rat and mouse liver, as well as the local and systemic thyroid hormone status after partial hepatectomy (PH). We observed that in rats, D3 activity was increased 10-fold at 20 h and 3-fold at 48 h after PH; D3 mRNA expression was increased 3-fold at 20 h. The increase in D3 expression was associated with maximum 2-to 3-fold decreases of serum and liver T-3 and T-4 levels at 20 to 24 h after PH. In mice, D3 activity was increased 5-fold at 12 h, 8-fold at 24 h, 40-fold at 36 h, 15-fold at 48 h, and 7-fold at 72 h after PH. In correlation with this, D3 mRNA was highest (6-fold increase), and serum T-3 and T-4 were lowest at 36 h. Furthermore, as a measure for cell proliferation, 5-bromo-2'-deoxyuridine incorporation peaked at 20-24 h after PH in rats and at 36 h in mice. No significant effect on D1 activity or mRNA expression was found after PH. D2 activity was always undetectable. In conclusion, we found a large induction of hepatic D3 expression after PH that was correlated with an increased cellular proliferation and decreased serum and liver T-3 and T-4 levels. Our data suggest that D3 is important in the modulation of thyroid hormone levels in the regenerating liver, in which a decrease in cellular T-3 permits an increase in proliferation. (Endocrinology 150: 540-545, 2009)
U2 - 10.1210/en.2008-0344
DO - 10.1210/en.2008-0344
M3 - Article
C2 - 18787028
SN - 0013-7227
VL - 150
SP - 540
EP - 545
JO - Endocrinology
JF - Endocrinology
IS - 1
ER -